CHEK2 and esophageal squamous cell carcinoma: Several genome‐wide association studies have identified a number of single nucleotide polymorphisms linked to the increased ESCC risk including ADH1B, PLCE1, genetic variants in HLA 2 genome region, CHEK2, PTEN, MTHFR, and so on.